Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models (Q38293424)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 March 2016

Language	Label	Description	Also known as
English	Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models	scientific article published on 3 March 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Kentaro Shinkai

1

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Kenji Nakano

2

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Lin Cui

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Yusuke Mizuuchi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Hideya Onishi

5

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Yoshinao Oda

6

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Satoshi Obika

7

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Masao Tanaka

8

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Mitsuo Katano

9

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

language of work or name

0 references

publication date

3 March 2016

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

139

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

433-445

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

The epidemiology of pancreatitis and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Pancreatic cancer surgery in the new millennium: better prediction of outcome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

The pleiotropic functions of the Y-box-binding protein, YB-1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

YB-1 protein: functions and regulation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

YB-1 overexpression promotes a TGF-β1-induced epithelial-mesenchymal transition via Akt activation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

LNA-based oligonucleotide electrotransfer for miRNA inhibition

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Mutual regulation between Raf/MEK/ERK signaling and Y-box-binding protein-1 promotes prostate cancer progression.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Effective transgene expression without toxicity by intraperitoneal administration of PEG-detachable polyplex micelles in mice with peritoneal dissemination.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

YB-1 autoregulates translation of its own mRNA at or prior to the step of 40S ribosomal subunit joining

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

p27 is regulated independently of Skp2 in the absence of Cdk2.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis in the absence of pRb and p53 tumor suppressors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Resectable Pancreatic Cancer: Who Really Benefits From Resection?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30075

21 January 2018

Identifiers

10.1002/IJC.30075

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38293424&oldid=1773790682"